Vijaya Diagnostic Centre Q2 FY27: revenue up 26.7% to ₹255 Cr, net profit up 37.4% to ₹60 Cr
Results · Finvezto · 4 Nov 2026 · Vijaya Diagnostic Centre (VIJAYA)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 255 | - | +26.7% |
| Operating profit | 113 | - | +37.8% |
| Net profit | 60 | - | +37.4% |
| Operating margin | 44.2% | - | +3.6 pp |
| Net margin | 23.3% | - | +1.8 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Q2 FY27 consolidated revenue was about INR 255 crore, up 26.7% year-on-year, driven by 16.5% volume growth, favorable test mix and the CGHS tariff revision. Earnings call
- EBITDA grew 37.8% year-on-year to about INR 113 crore with a 44.1% margin, up 350 basis points on operating leverage, and PAT rose 37.4% to INR 59 crore. Earnings call
- Hyderabad grew over 20% year-on-year, Pune about 15.5% on a clear turnaround, and West Bengal showed encouraging momentum as newer centers and brand awareness strengthen. Earnings call
What to watch
- Management on fy27 revenue growth: So, we are fairly confident that for this financial year, we will be growing at least like a 20% growth rate is fairly achievable for this financial year.
- Management on long-term revenue growth: Considering this expansion for a long-term sustainable revenue guidance for a period of like three to five years, we'll be comfortable in achieving mid-teen growth of close to like above 15% revenue guidance is fairly achievable.
Links
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.